About Wild Card
Don’t wait for a game-changer
Become one
We create new business ventures from teams and individuals with big ideas – people who are not afraid to defy convention, take a risk and with our help, create products and services that could change people’s lives.
About Wild Card
The Challenges
Choose your challenge
Calling all inventors, creators and self-starters – we challenge you to improve the health of people and patients in Europe.
Can you transform...
Women's
Health
How to improve prediction, diagnosis and treatment to advance women’s health outcomes?
Learn moreCan you transform...
Digital
Therapeutics
How to harness the power of digital solutions to prevent, manage and treat medical conditions or disease?
Learn moreThe Process
Become a Wild Card
The annual call is open to innovators who want to change the course of their future and ours. Wild Card provides world-class training and mentoring, and the opportunity to create a venture with up to €2 million investment.
HOW TO APPLY
Stage 1
Apply
Apply with or without a big idea if you have clinical expertise, top technical skills or business know-how combined with a passion for the challenge topics.
Stage 2
Hackathon
Chosen Wild Card participants are invited to an intensive week-long training session to form a team, develop a business plan and pitch their ideas.
Stage 3
Validate
Successful pitches begin a 10-week programme led by industry experts to validate the business proposals and pitch to the EIT Health Panel.
Stage 4
Venture
Two chosen ventures will receive EIT Health support, resources and €2 million investment over the next two years to develop and establish their businesses.
Wild Cards
Meet the Wild Cards
Discover the ventures Wild Card has invested in and be inspired by their founders – innovators who started off like you – who built their new company through the Wild Card journey.
Wild Cards
Wild Card
Abtrace
Every use of an antibiotic comes with a risk that resistance might develop. Abtrace is using artificial intelligence to tackle AMR – perhaps the greatest global health threat of our time.
View Wild Card
Wild Card
Smart4Diagnostics
Digital innovations are taking diagnostics from a trust-based system into an accurate, evidence-based system. Smart4Diagnostics closes the data gap between blood collection and lab analysis.
View Wild Card
Wild Card
iLoF
Harnessing biophotonics and artificial intelligence to unlock new possibilities in Alzheimer’s drug discovery. iLoF is creating a pathway which promotes breakthroughs in Alzheimer's disease research.
View Wild Card
Wild Card
PIPRA
Disorientation, memory loss and speech difficulties are some of the symptoms of post-operative cognitive complications in the over-60s. PIPRA, short for Pre-interventional Preventative Risk Assessment, is developing a risk score in-app intervention for pre and post-operative patients.
View Wild CardIncubators
This is only the beginning
The two chosen ventures will embed themselves in a Wild Card incubator of their choosing in Europe. Wild Card is not just a project, teams will need to relocate and focus full-time on building their new start-up with support from EIT Health, the largest healthcare network in Europe.
News & Events
Read the latest news and events from Wild Card.
See all News & Events
Wild Card Hackathon goes virtual
Extraordinary times call for extraordinary measures. With respect for the time and all the great work Wild Card participants are doing we have decided to create a virtual experience, having in mind all the most important components of the physical event we would host
Read more
2020 programme timeline updated
We took note of the health risk associated with a few dozens of participants and mentors travelling to attend Wild Card Hackathon in the face of the current Coronavirus situation in Europe. We feel that adjusting programme's timeline to counteract the impact of Coronavirus is the right thing to do.
Read more
The webinar recording is online!
We recorded the webinar for your convenience. Learn what the Wild Card is and what it isn’t and how to submit successful application.
Read more